Standards of lithium monitoring in mental health trusts in the UK

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Collins, Noel ^a,b   Barnes, Thomas R E ^b,c   Shingleton Smith, Amber ^b   Gerrett, David ^d   Paton, Carol ^b,c  

^a Greater London House ^*  (United Kingdom)

^b ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL PATIENT SAFETY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; LITHIUM DERIVATIVE;

ADULT; AGED; ARTICLE; DRUG MONITORING; FEMALE; HUMAN; KIDNEY FUNCTION TEST; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MENTAL HOSPITAL; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; STANDARD; THYROID FUNCTION TEST; UNITED KINGDOM; BIPOLAR DISORDER; CLINICAL PRACTICE; DRUG TOXICITY; ELECTRONIC PRESCRIBING; MEDICAL AUDIT; METHODOLOGY; QUALITY CONTROL; QUESTIONNAIRE; SAFETY; STATISTICS;

BENCHMARKING; BIPOLAR DISORDER; COMMISSION ON PROFESSIONAL AND HOSPITAL ACTIVITIES; DRUG MONITORING; DRUG PRESCRIPTIONS; DRUG TOXICITY; ELECTRONIC PRESCRIBING; GREAT BRITAIN; HUMANS; KIDNEY FUNCTION TESTS; LITHIUM COMPOUNDS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; SAFETY MANAGEMENT; THYROID FUNCTION TESTS;

EID: 77957726081     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-80     Document Type: Article

References (34)

1. Goodwin GM. Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003, 17:149-173. 10.1177/0269881103017002003, 12870562.
2. National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care - clinical guideline 90. 2009, http://guidance.nice.org.uk/CG90/Guidance/pdf/English
3. National Institute for Clinical Excellence. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Clinical Guideline 38 2006, http://guidance.nice.org.uk/CG38/Guidance/pdf/English
4. Goodwin GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994, 164:149-152. 10.1192/bjp.164.2.149, 8173817.
5. Anon Drug treatments for bipolar disorder: maintenance, prevention and special situations. Drug and Therapeutics Bulletin 2005, 43:33-37. 10.1136/dtb.2005.43533, 15903113, Anon.
6. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol 2006, 20:347-355. 10.1177/0269881105057515, 16174674.
7. National Institute for Health and Clinical Excellence. About the Quality and Outcomes Framework. , http://www.nice.org.uk/aboutnice/qof/qof.jsp
8. Glover KJ, Lawley D. How safe is lithium prescribing? Audit of a local prescribing framework and patient survey. Psychiatr Bull 2005, 29:98-100.
9. Kehoe RF, Mander AJ. Lithium treatment: prescribing and monitoring habits in hospital and general practice. BMJ 1992, 304:552-554. 10.1136/bmj.304.6826.552, 1881375, 1559064.
10. Fielding S, Kerr S, Godber C. Lithium in the over-65s-a dedicated monitoring service leads to a better quality of treatment supervision. Int J Geriatr Psychiatry 1999, 14:985-987. 10.1002/(SICI)1099-1166(199911)14:11<985::AID-GPS57>3.0.CO;2-S, 10556872.
11. Eagles JM, McCann I, MacLeod TN, Paterson N. Lithium monitoring before and after the distribution of clinical practice guidelines. Acta Psychiatr Scand 2000, 101:349-353. 10.1034/j.1600-0447.2000.101005349.x, 10823293.
12. Buckley C, Sharrard H. Lithium monitoring for patients with learning disability: the role of the general practitioner. Quality in Primary Care 2003, 11:329-331.
13. Farooqi A, Smith J, Lakhani M, Meakin C, Sorrie R, Ashmore S, et al. The impact and acceptability of a central register on the standard of monitoring of lithium therapy: professional and patient perspectives. Journal of Clinical Governance 2002, 10:121-126.
14. Byng RM. The development and formative evaluation of a complex intervention to improve shared care for patients with long-term mental illness. Journal of Evaluation in Clinical Practice 2004, 10:27-36. 10.1111/j.1365-2753.2003.00439.x, 14731149.
15. Holmes B. If you want a job done properly, do it yourself - setting up a county-wide lithium database. Bipolar Disorders 2003, 5(Suppl 1):53.
16. Holmes B. The Norfolk-wide lithium database: the answer, or more questions?. Bipolar Disorders Supplement 2005, 7(Suppl 2):65.
17. Egan TM, Grigor JM. Monitoring lithium treatment. BMJ 1992, 305:52-53. 10.1136/bmj.305.6844.52-d, 1882503, 1638214.
18. Simpson J, Benbow SM. Recent audit of people taking lithium. Psychiatr Bull 1999, 23:241-246.
19. Marcus S. Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. American Journal of Psychiatry 1991, 156:1014-1018.
20. Newcomer JW, Nasrallah HA, Loebel AD. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: Practice Patterns and Knowledge of Psychiatrists. Journal of Clinical Psychopharmacology 2004, 24:1-6. 10.1097/01.jcp.0000142281.85207.d5, 14709939.
21. Barnes TRE, Paton C, Cavanagh MR, Hancock E, Taylpr DM, . on behalf of the UK Prescribing Observatory for Mental Health A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 2007, 33:1397-1403. 10.1093/schbul/sbm038, 2779874, 17483101, on behalf of the UK Prescribing Observatory for Mental Health.
22. King JR, Birch NJ. Delayed response to abnormal lithium results is no longer necessary. Psychiatr Bull 1998, 22:471-473.
23. Head L, Dening T. Lithium in the over-65s: who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int J Geriatr Psychiatry 1998, 13:164-171. 10.1002/(SICI)1099-1166(199803)13:3<164::AID-GPS749>3.0.CO;2-U, 9565838.
24. Waddington D. GP monitoring of lithium levels. Br J Psychiatry 1996, 168:383. 10.1192/bjp.168.3.383a, 8833700.
25. McKee J, . medication safety, medication therapy management, psychiatric pharmacy High-Risk, High-Alert Medication Management Practices in a Regional State Psychiatric Facility. Hospital Pharmacy 2007, 42:323-330. medication safety, medication therapy management, psychiatric pharmacy.
26. Kotak A, Arnold AE, Frost P. Monitoring lithium treatment: Evaluation of current management. Psychiatr Bull 1999, 23:83-86.
27. The Information Centre for Social Care. Quality and Outcomes Framework (QOF) for April 2008 - March 2009, England. , http://www.ic.nhs.uk/webfiles/QOF/2008-09/England%20tables/QOF0809_National_Clinical.xls
28. Smith J. Education with an angle. BMJ 2009, 338:1548.
29. Mangin D, Toop L. The Quality and Outcomes Framework: what have you done to yourselves?. Br J Gen Pract 2007, 57:435-437. 2078175, 17550665.
30. Weel C, Weel-Baumgarten E, Rijswijk E. Treatment of depression in primary care. BMJ 2009, 338:934.
31. Paton C, Barnes TRE, Shingleton-Smith A, McAllister-Williams RH, Kirkbride J, Jones PB, McIntyre S, . on behalf of the POMH-UK project team Lithium in bipolar and other affective disorders: prescribing practice in the UK. Journal of Psychopharmacology 2010, on behalf of the POMH-UK project team.
32. National Patient Safety Agency Safer lithium therapy. Patient Safety Alert, NPSA/2009/PSA005, 1st December 2009. National Patient Safety Agency.
33. Patient information booklet, lithium alert card and record book. 1st December 2009. , http://www.nrls.npsa.nhs.uk/resources/type/alerts/?entryid45=65426
34. Ryman A. Lithium monitoring in hospital and general practice. The Psychiatrist 1997, 21:570-572.